accountfor an array of medical devices will also be showcased. Greater details will be presented for how well Bayer AG's (BAYGn.DE Preliminary data from the Phase III study were released two weeks ago, showing the oral medication was at least as good as the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to PREVIEW-Closely watched heart drugs highlight AHA meeting
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account